{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T15:06:21Z","timestamp":1782831981519,"version":"3.54.5"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6,2]]},"abstract":"<jats:p>Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease that leads to progressive dyspnea and dry cough, with extracellular matrix deposition as the main pathological feature. Yifei Tongluo granules (YTG) are a traditional Chinese medicine formula that could nourish Qi-Yin, clear phlegm, and invigorate blood circulation. In this research, network pharmacology and molecular docking were used to elucidate the potential mechanism of YTG for treating IPF. A total of 278 biologically active compounds were included in YTG, and 16 compounds were selected for pharmacological analysis and molecular docking through \u201cdrugs-compounds-intersecting targets of YTG and IPF\u201d network construction. Protein-protein interaction network was constructed using 330 YTG-IPF intersecting targets. Furthermore, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis were performed. A total of 10 core targets were screened by protein-protein interaction, and molecular docking was used to further validate the binding ability of the compounds to the core targets. The network pharmacology and molecular docking results showed that Danshenol A, isorhamnetin, Ginsenoside-Rh4, quercetin, and kaempferol might be the main active compounds in the treatment of IPF by YTG, whereas MAPK1, MAPK3, EGFR, and SRC are the core targets while PI3K\/AKT pathway and MAPK pathway are the main signaling pathways through which YTG regulates relevant biological processes to intervene in IPF. This study shows that YTG can treat IPF by inhibiting the epithelial-mesenchymal transit process, fibroblast proliferation, fibroblast-to-myofibroblast conversion, myofibroblast anti-apoptosis, collagen expression, and other mechanisms.YTG can be widely used as an adjuvant therapy for IPF in clinical practice, and this study provides the basis for subsequent experimental studies.<\/jats:p>","DOI":"10.1097\/md.0000000000033729","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T15:12:43Z","timestamp":1685718763000},"page":"e33729","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Network pharmacology and molecular docking to explore the pharmacological mechanism of Yifei Tongluo granules in treating idiopathic pulmonary fibrosis: A review"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5700-7081","authenticated-orcid":false,"given":"Yuan","family":"Hou","sequence":"first","affiliation":[{"name":"Institute of Chinese Medicine Documentation and Culture, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Beijing Shijitan Hospital Affiliated to Capital University of Medical Sciences, Beijing, China"},{"name":"China Emergency Department, Zhangdian District Traditional Chinese Medicine Hospital, ZiBo, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Han","sequence":"additional","affiliation":[{"name":"Emergency Department, Zhangdian District Traditional Chinese Medicine Hospital, ZiBo, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaman","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Diseases, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev-pathol-042320-030240","article-title":"Pathogenic mechanisms underlying idiopathic pulmonary fibrosis.","volume":"17","author":"Moss","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00018-020-03693-7","article-title":"Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis.","volume":"78","author":"Phan","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"L1025","DOI":"10.1152\/ajplung.00526.2018","article-title":"Epidermal growth factor receptor paracrine upregulation in idiopathic pulmonary fibrosis fibroblasts is blocked by nintedanib.","volume":"316","author":"Epstein","year":"2019","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery.","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat Chem Biol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines.","volume":"6","author":"Ru","year":"2014","journal-title":"J Cheminform"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules.","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.drudis.2014.08.008","article-title":"PubChem applications in drug discovery: a bibliometric analysis.","volume":"19","author":"Cheng","year":"2014","journal-title":"Drug Discov Today"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1021\/acs.jcim.6b00174","article-title":"SwissSimilarity: a web tool for low to ultra high throughput ligand-based virtual screening.","volume":"56","author":"Zoete","year":"2016","journal-title":"J Chem Inf Model"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"103613","DOI":"10.1016\/j.jprot.2019.103613","article-title":"UniprotR: retrieving and visualizing protein sequence and functional information from universal protein resource (UniProt knowledgebase).","volume":"213","author":"Soudy","year":"2020","journal-title":"J Proteomics"},{"key":"R10-20250504","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab108","article-title":"Venn diagrams in bioinformatics.","volume":"22","author":"Jia","year":"2021","journal-title":"Brief Bioinform"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets.","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.","volume":"4","author":"Huang","year":"2009","journal-title":"Nat Protoc"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/acs.jcim.9b00778","article-title":"Autodock vina adopts more accurate binding poses but autodock4 forms better binding affinity.","volume":"60","author":"Nguyen","year":"2020","journal-title":"J Chem Inf Model"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/labinvest.2013.137","article-title":"Inhibition of airway epithelial-to-mesenchymal transition and fibrosis by kaempferol in endotoxin-induced epithelial cells and ovalbumin-sensitized mice.","volume":"94","author":"Gong","year":"2014","journal-title":"Lab Invest"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1139\/bcb-2017-0302","article-title":"Quercetin ameliorates pulmonary fibrosis by inhibiting SphK1\/S1P signaling.","volume":"96","author":"Zhang","year":"2018","journal-title":"Biochem Cell Biol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1165\/rcmb.2017-0289OC","article-title":"Quercetin enhances ligand-induced apoptosis in senescent idiopathic pulmonary fibrosis fibroblasts and reduces lung fibrosis in vivo.","volume":"60","author":"Hohmann","year":"2019","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R18-20250504","first-page":"163","article-title":"Salvia miltiorrhiza: traditional medicinal uses, chemistry, and pharmacology.","volume":"13","author":"Su","year":"2015","journal-title":"Chin J Nat Med"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"999604","DOI":"10.3389\/fphar.2022.999604","article-title":"Salvia miltiorrhiza in thorax and abdomainal organ fibrosis: a review of its pharmacology.","volume":"13","author":"Yang","year":"2022","journal-title":"Front Pharmacol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejphar.2016.04.042","article-title":"Isorhamnetin attenuates liver fibrosis by inhibiting TGF-beta\/Smad signaling and relieving oxidative stress.","volume":"783","author":"Yang","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"R21-20250504","first-page":"117","article-title":"Isorhamnetin protects against bleomycin-induced pulmonary fibrosis by inhibiting endoplasmic reticulum stress and epithelial-mesenchymal transition.","volume":"43","author":"Zheng","year":"2019","journal-title":"Int J Mol Med"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jep.2016.05.018","article-title":"Evaluation of the anti-inflammatory activities of tanshinones isolated from Salvia miltiorrhiza var. alba roots in THP-1 macrophages.","volume":"188","author":"Ma","year":"2016","journal-title":"J Ethnopharmacol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1038\/s41598-017-13072-1","article-title":"Danshenol A inhibits TNF-alpha-induced expression of intercellular adhesion molecule-1 (ICAM-1) mediated by NOX4 in endothelial cells.","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci Rep"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"2580409","DOI":"10.1155\/2019\/2580409","article-title":"Danshenol A alleviates hypertension-induced cardiac remodeling by ameliorating mitochondrial dysfunction and suppressing reactive oxygen species production.","volume":"2019","author":"Chen","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/cells11060986","article-title":"EGFR signaling in lung fibrosis.","volume":"11","author":"Schramm","year":"2022","journal-title":"Cells"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"110183","DOI":"10.1016\/j.biopha.2020.110183","article-title":"SRC family kinases and pulmonary fibrosis: a review.","volume":"127","author":"Li","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.phrs.2012.04.005","article-title":"ERK1\/2 MAP kinases: structure, function, and regulation.","volume":"66","author":"Roskoski","year":"2012","journal-title":"Pharmacol Res"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1080\/21655979.2021.1944020","article-title":"Danshensu alleviates bleomycin-induced pulmonary fibrosis by inhibiting lung fibroblast-to-myofibroblast transition via the MEK\/ERK signaling pathway.","volume":"12","author":"Liu","year":"2021","journal-title":"Bioengineered"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbrc.2018.03.039","article-title":"Leptin promotes pulmonary fibrosis development by inhibiting autophagy via PI3K\/Akt\/mTOR pathway.","volume":"498","author":"Gui","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1183\/09031936.00077309","article-title":"Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology.","volume":"35","author":"Vancheri","year":"2010","journal-title":"Eur Respir J"},{"key":"R31-20250504","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030593","article-title":"Idiopathic pulmonary fibrosis and lung cancer: mechanisms and molecular targets.","volume":"20","author":"Ballester","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3109\/10799893.2010.489227","article-title":"Expression analysis of Akt and MAPK signaling pathways in lung tissue of patients with idiopathic pulmonary fibrosis (IPF).","volume":"30","author":"Antoniou","year":"2010","journal-title":"J Recept Signal Transduct Res"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"e0127888e127888","DOI":"10.1371\/journal.pone.0127888","article-title":"DA-Raf-mediated suppression of the ras \u2013 ERK pathway is essential for TGF-beta1-induced epithelial-mesenchymal transition in alveolar epithelial type 2 cells.","volume":"10","author":"Watanabe-Takano","year":"2015","journal-title":"PLoS One"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/s41418-018-0175-7","article-title":"Paracrine signalling during ZEB1-mediated epithelial-mesenchymal transition augments local myofibroblast differentiation in lung fibrosis.","volume":"26","author":"Yao","year":"2019","journal-title":"Cell Death Differ"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1165\/rcmb.2011-0237OC","article-title":"MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation.","volume":"46","author":"Madala","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"e61017","DOI":"10.1371\/journal.pone.0061017","article-title":"FoxO3a (Forkhead Box O3a) deficiency protects idiopathic pulmonary fibrosis (IPF) fibroblasts from type I polymerized collagen matrix-induced apoptosis via caveolin-1 (cav-1) and Fas.","volume":"8","author":"Nho","year":"2013","journal-title":"PLoS One"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033729","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:10:32Z","timestamp":1746324632000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,2]]},"references-count":36,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033729","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,2]]}}}